DaVita Careers

Buzz & Blogs

Are you looking for the latest DaVita news and teammate blogs? If so, you came to the right place! Below you will find a compilation of "Day in the Life" teammate blogs, articles written about DaVita and press releases.

« Back to Buzz & Blogs

Study Finds That Dialysis Patients Who Use DaVita Rx Live Longer

April 24, 2013  | Press Releases

Improved Mortality and Fewer Hospital Stays for Dialysis Patients Using DaVita Rx Pharmacy

DALLAS--(BUSINESS WIRE)--Apr. 24, 2013-- DaVita®, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced study results showing that, on average, patients using its pharmacy, DaVita Rx®, are 21 percent more likely to live longer than patients who do not use DaVita Rx.

The study, recently published by the American Journal of Kidney Diseases, also found that dialysis patients who use DaVita Rx spent 14 percent fewer days in the hospital each year, which equates to 1.8 fewer hospital days per patient per year. The independent study was conducted by the Chronic Disease Research Group (CDRG), who analyzed the hospitalizations and mortality of more than 50,000 DaVita patients.

“We created DaVita Rx in 2005 because we knew it would make a difference in the lives of our patients,” said Kent Thiry, co-chairman and CEO of DaVita HealthCare Partners. “We have critically ill patients who often take more than 20 pills per day, prescribed by multiple physicians, in addition to hours of dialysis treatments. This study confirms our belief that a pharmacy program can improve mortality, clinical outcomes and quality of life.”

The CDRG obtained data for this study through the United States Renal Data System. The study’s control group was made of 43,013 DaVita patients using other pharmacies to receive their medications. The study group of 8,864 DaVita patients used the DaVita Rx pharmacy service over the 2.5 years between 2006 and 2008.
DaVita Rx is the world’s first and largest full-service pharmacy specializing in kidney care, serving a growing percentage of dialysis patients at DaVita and other dialysis providers. Suffering from end stage renal disease and often other chronic illnesses, these patients receive medications while dialyzing at their local dialysis center or at home. Patients also benefit from services including 24-hour access to specially-trained pharmacists, flexible payment options, refill reminders and insurance assistance.

For more information on DaVita, please visit www.DaVita.com. To learn more about DaVita Rx and this study, please visit www.DaVitaRx.com.

» Read More